| The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. | |
| | |
MedLine Citation:
|
PMID: 21367734 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
For individuals with human immunodeficiency virus (HIV) infection to fully benefit from potent combination antiretroviral therapy, they need to know that they are HIV infected, be engaged in regular HIV care, and receive and adhere to effective antiretroviral therapy. Test-and-treat strategies for HIV prevention posit that expanded testing and earlier treatment of HIV infection could markedly decrease ongoing HIV transmission, stemming the HIV epidemic. However, poor engagement in care for HIV-infected individuals will substantially limit the effectiveness of test-and-treat strategies. We review the spectrum of engagement in care for HIV-infected individuals in the United States and apply this information to help understand the magnitude of the challenges that poor engagement in care will pose to test-and-treat strategies for HIV prevention. |
| | |
Authors:
|
Edward M Gardner; Margaret P McLees; John F Steiner; Carlos Del Rio; William J Burman |
Related Documents
:
|
21423024 - Tuberculosis risk before and after highly active antiretroviral therapy initiation: doe... 12454814 - Cryptogenic cirrhosis: clinicopathologic findings at and after liver transplantation. 21284854 - Unsuspected pulmonary alveolar proteinosis in a patient with acquired immunodeficiency ... 11799484 - A prospective randomized trial of mycophenolate mofetil in liver transplant recipients ... 16640104 - Antiviral efficacy and genotypic resistance patterns of combination therapy with stavud... 21473954 - Prevalence of protective level of hepatitis b antibody 3 years after revaccination in h... |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural; Review |
Journal Detail:
|
Title: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Volume: 52 ISSN: 1537-6591 ISO Abbreviation: Clin. Infect. Dis. Publication Date: 2011 Mar |
Date Detail:
|
Created Date: 2011-03-03 Completed Date: 2011-06-07 Revised Date: 2012-09-20 |
Medline Journal Info:
|
Nlm Unique ID: 9203213 Medline TA: Clin Infect Dis Country: United States |
Other Details:
|
Languages: eng Pagination: 793-800 Citation Subset: IM |
Affiliation:
|
Denver Public Health, Denver, Colorado, USA. edward.m.gardner@dhha.org |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Anti-HIV Agents
/
therapeutic use* Antiretroviral Therapy, Highly Active / methods* HIV Infections / diagnosis*, drug therapy, prevention & control* Humans Patient Acceptance of Health Care / statistics & numerical data* United States |
| Grant Support | |
ID/Acronym/Agency:
|
K01 AI067063/AI/NIAID NIH HHS; R34 MH090870/MH/NIMH NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Anti-HIV Agents |
| Comments/Corrections | |
Comment In:
|
Clin Infect Dis. 2011 Mar 15;52(6):801-2
[PMID:
21367735
]
Clin Infect Dis. 2011 Dec;53(11):1168-9; author's reply 1169-70 [PMID: 21976466 ] |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Vibrio vulnificus oysters: pearls and perils.
Next Document: Cumulative exposure to cell-free HIV in breast milk, rather than feeding pattern per se, identifies ...